Sign In
Buy MED
$10.62
-0.400 (-3.63%)
At Close: Jun 23, 2026
3 Stocks to Sell as Ozempic Surges in Popularity
06:37am, Friday, 14'th Jun 2024
Novo Nordisk's (NYSE: NVO ) Ozempic diabetes treatment, marketed as a weight loss treatment under the Wegovy brand name, has become the latest mega-blockbuster drug. Yet, while you may be thinking abo
7 Small-Cap Value Stocks Leaving the S&P 500 in the Dust
01:20pm, Wednesday, 12'th Jun 2024
Even as the S&P 500 reaches new highs, some investors view small-cap value stocks as the best option for long-term growth. Concerns are growing about the concentration of investments in index-based st
Medifast (MED) Tumbles More Than 40% in 3 Months: Here's Why
09:26am, Tuesday, 11'th Jun 2024
Medifast (MED) battles persistent customer acquisition challenges aggravated by macroeconomic factors and the rising popularity of weight loss medications.
The Schall Law Firm Is Initiating An Investigation Into Accusations Against Medifast, Inc. And Urges Investor Engagement
11:00am, Sunday, 09'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
The Schall Law Firm Announces A Probe Into Allegations Against Medifast, Inc. And Encourages Investor Involvement
11:00am, Saturday, 08'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
KKR, CrowdStrike Holdings and GoDaddy Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
06:09pm, Friday, 07'th Jun 2024
NEW YORK , June 7, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of t
The Schall Law Firm Declares An Investigation Into Claims Against Medifast, Inc. And Invites Investor Participation
01:30pm, Friday, 07'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
The Schall Law Firm Announces An Inquiry Into Allegations Against Medifast, Inc. And Encourages Investor Engagement
12:30pm, Thursday, 06'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
The Schall Law Firm Proclaims an Investigation into Accusations Against Medifast, Inc. and Urges Investor Communication
02:45pm, Tuesday, 04'th Jun 2024
LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("M
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Medifast, Inc. ("Medifast" or "the Company") (NYSE:MED) for viol
7 Underappreciated Stocks With 25% Return Potential in 2024
06:10am, Thursday, 30'th May 2024
Whether investors refer to them as undervalued or hidden gems, underappreciated stocks are always worth considering. Investors have made fortunes, large and small, by identifying underappreciated sha
